Eli Lilly’s Verzenio Picks Up Third Approved Indication Post author:Sam Post published:February 26, 2018 Post category:BioPharma Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace You Might Also Like Why Bluebird Bio Investors Aren't Singing the Blues December 12, 2017 CMOs Cringe as GlaxoSmithKline Will be Cutting Its Use by 25% July 27, 2017 Why This Alzheimer's Biotech May Not Live to See 2020 March 5, 2017
